These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 31120420)

  • 21. A critical role of the C-terminal segment for allosteric inhibitor-induced aberrant multimerization of HIV-1 integrase.
    Shkriabai N; Dharmarajan V; Slaughter A; Kessl JJ; Larue RC; Feng L; Fuchs JR; Griffin PR; Kvaratskhelia M
    J Biol Chem; 2014 Sep; 289(38):26430-26440. PubMed ID: 25118283
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Discovery and Optimization of Novel Pyrazolopyrimidines as Potent and Orally Bioavailable Allosteric HIV-1 Integrase Inhibitors.
    Li G; Meanwell NA; Krystal MR; Langley DR; Naidu BN; Sivaprakasam P; Lewis H; Kish K; Khan JA; Ng A; Trainor GL; Cianci C; Dicker IB; Walker MA; Lin Z; Protack T; Discotto L; Jenkins S; Gerritz SW; Pendri A
    J Med Chem; 2020 Mar; 63(5):2620-2637. PubMed ID: 32081010
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Distribution and Redistribution of HIV-1 Nucleocapsid Protein in Immature, Mature, and Integrase-Inhibited Virions: a Role for Integrase in Maturation.
    Fontana J; Jurado KA; Cheng N; Ly NL; Fuchs JR; Gorelick RJ; Engelman AN; Steven AC
    J Virol; 2015 Oct; 89(19):9765-80. PubMed ID: 26178982
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HIV-1 Resistance to Dolutegravir Is Affected by Cellular Histone Acetyltransferase Activity.
    Anstett K; Brenner B; Mesplède T; Wainberg MA
    J Virol; 2017 Nov; 91(21):. PubMed ID: 28835492
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multifaceted HIV integrase functionalities and therapeutic strategies for their inhibition.
    Engelman AN
    J Biol Chem; 2019 Oct; 294(41):15137-15157. PubMed ID: 31467082
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Methods for the Analyses of Inhibitor-Induced Aberrant Multimerization of HIV-1 Integrase.
    Kessl JJ; Sharma A; Kvaratskhelia M
    Methods Mol Biol; 2016; 1354():149-64. PubMed ID: 26714710
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The structural and mechanistic bases for the viral resistance to allosteric HIV-1 integrase inhibitor pirmitegravir.
    Dinh T; Tber Z; Rey JS; Mengshetti S; Annamalai AS; Haney R; Briganti L; Amblard F; Fuchs JR; Cherepanov P; Kim K; Schinazi RF; Perilla JR; Kim B; Kvaratskhelia M
    mBio; 2024 Nov; 15(11):e0046524. PubMed ID: 39404354
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Allosteric Integrase Inhibitor Influences on HIV-1 Integration and Roles of LEDGF/p75 and HDGFL2 Host Factors.
    Singh PK; Li W; Bedwell GJ; Fadel HJ; Poeschla EM; Engelman AN
    Viruses; 2022 Aug; 14(9):. PubMed ID: 36146690
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis, Molecular Modelling and Biological Studies of 3-hydroxypyrane- 4-one and 3-hydroxy-pyridine-4-one Derivatives as HIV-1 Integrase Inhibitors.
    Sirous H; Fassihi A; Brogi S; Campiani G; Christ F; Debyser Z; Gemma S; Butini S; Chemi G; Grillo A; Zabihollahi R; Aghasadeghi MR; Saghaie L; Memarian HR
    Med Chem; 2019; 15(7):755-770. PubMed ID: 30569867
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The R263K Dolutegravir Resistance-Associated Substitution Progressively Decreases HIV-1 Integration.
    Mesplède T; Leng J; Pham HT; Liang J; Quan Y; Han Y; Wainberg MA
    mBio; 2017 Apr; 8(2):. PubMed ID: 28377526
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of an AlphaScreen-based HIV-1 integrase dimerization assay for discovery of novel allosteric inhibitors.
    Demeulemeester J; Tintori C; Botta M; Debyser Z; Christ F
    J Biomol Screen; 2012 Jun; 17(5):618-28. PubMed ID: 22337657
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Allosteric HIV-1 integrase inhibitors promote aberrant protein multimerization by directly mediating inter-subunit interactions: Structural and thermodynamic modeling studies.
    Deng N; Hoyte A; Mansour YE; Mohamed MS; Fuchs JR; Engelman AN; Kvaratskhelia M; Levy R
    Protein Sci; 2016 Nov; 25(11):1911-1917. PubMed ID: 27503276
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Drug-Induced Interface That Drives HIV-1 Integrase Hypermultimerization and Loss of Function.
    Singer MR; Dinh T; Levintov L; Annamalai AS; Rey JS; Briganti L; Cook NJ; Pye VE; Taylor IA; Kim K; Engelman AN; Kim B; Perilla JR; Kvaratskhelia M; Cherepanov P
    mBio; 2023 Feb; 14(1):e0356022. PubMed ID: 36744954
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structure-function analyses unravel distinct effects of allosteric inhibitors of HIV-1 integrase on viral maturation and integration.
    Bonnard D; Le Rouzic E; Eiler S; Amadori C; Orlov I; Bruneau JM; Brias J; Barbion J; Chevreuil F; Spehner D; Chasset S; Ledoussal B; Moreau F; Saïb A; Klaholz BP; Emiliani S; Ruff M; Zamborlini A; Benarous R
    J Biol Chem; 2018 Apr; 293(16):6172-6186. PubMed ID: 29507092
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Kuwanon-L as a New Allosteric HIV-1 Integrase Inhibitor: Molecular Modeling and Biological Evaluation.
    Esposito F; Tintori C; Martini R; Christ F; Debyser Z; Ferrarese R; Cabiddu G; Corona A; Ceresola ER; Calcaterra A; Iovine V; Botta B; Clementi M; Canducci F; Botta M; Tramontano E
    Chembiochem; 2015 Nov; 16(17):2507-12. PubMed ID: 26360521
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structural Basis for Inhibitor-Induced Aggregation of HIV Integrase.
    Gupta K; Turkki V; Sherrill-Mix S; Hwang Y; Eilers G; Taylor L; McDanal C; Wang P; Temelkoff D; Nolte RT; Velthuisen E; Jeffrey J; Van Duyne GD; Bushman FD
    PLoS Biol; 2016 Dec; 14(12):e1002584. PubMed ID: 27935939
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In search of second-generation HIV integrase inhibitors: targeting integration beyond strand transfer.
    Voet AR; Maeyer MD; Debyser Z; Christ F
    Future Med Chem; 2009 Oct; 1(7):1259-74. PubMed ID: 21426102
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Allosteric inhibition of human immunodeficiency virus integrase: late block during viral replication and abnormal multimerization involving specific protein domains.
    Gupta K; Brady T; Dyer BM; Malani N; Hwang Y; Male F; Nolte RT; Wang L; Velthuisen E; Jeffrey J; Van Duyne GD; Bushman FD
    J Biol Chem; 2014 Jul; 289(30):20477-88. PubMed ID: 24904063
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Extracting functional groups of ALLINI to design derivatives of FDA-approved drugs: Inhibition of HIV-1 integrase.
    Kalathiya U; Padariya M; Baginski M
    Biotechnol Appl Biochem; 2018 Jul; 65(4):594-607. PubMed ID: 29405478
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Critical Contribution of Tyr15 in the HIV-1 Integrase (IN) in Facilitating IN Assembly and Nonenzymatic Function through the IN Precursor Form with Reverse Transcriptase.
    Takahata T; Takeda E; Tobiume M; Tokunaga K; Yokoyama M; Huang YL; Hasegawa A; Shioda T; Sato H; Kannagi M; Masuda T
    J Virol; 2017 Jan; 91(1):. PubMed ID: 27795445
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.